Immunovant, Inc. IMVT Pre-Tax Income
Pre-Tax Income at other companies
Segments
By geography
See fullOther financials
Where this comes from
Reported directly by Immunovant, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest.
The official record: Immunovant, Inc.’s 10-K, filed May 20, 2026, on SEC EDGAR. View the filing →
Ask your AI about Immunovant, Inc.'s pre-tax income.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Immunovant, Inc.'s pre-tax income?
- Immunovant, Inc. (IMVT) reported pre-tax income of -$150.7M in Q1 2026.
- How has Immunovant, Inc.'s pre-tax income changed year-over-year?
- Immunovant, Inc.'s pre-tax income decreased by 42.3% year-over-year, from -$105.87M to -$150.7M.
- What is the long-term trend for Immunovant, Inc.'s pre-tax income?
- Over 4 years (2022 to 2026), Immunovant, Inc.'s pre-tax income has grown at a 34.0% compound annual growth rate (CAGR), from -$156.81M to -$505.39M.
- What does pre-tax income mean?
- Total income from all sources — operating income plus non-operating items like interest income, investment gains, and other income — before the provision for income taxes.